ISRCTN ISRCTN73431052
DOI https://doi.org/10.1186/ISRCTN73431052
Secondary identifying numbers N/A
Submission date
30/09/2008
Registration date
31/10/2008
Last edited
30/12/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Jawad Mustafa
Scientific

South Infirmary Hospital
Cork
-
Ireland

Study information

Study designSingle blinded, prospective, randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleEfficacy of Sub-Tenon's block using an equal volume of local anaesthestic administered either as a single or as divided doses
Study acronymSubTenon
Study objectivesOur hypothesis was that a divided injection into the Sub-Tenon’s space would achieve greater, more consistent and more rapid motor blockade then a single injection using equal volumes and mixtures of local anaesthetic solution.
Ethics approval(s)Ethics Committee of Cork University Hospital, approval received in 2003.
Health condition(s) or problem(s) studiedCataract surgery
InterventionOn arrival in the induction room, intravenous excess was secured and monitoring with non-invasive blood pressure (NIBP), electrocardiogram (ECG), and pulse oximetry (Datex AS3) established. Topical anaesthesia was established by instillation of benoximate eye drops and after 2 minutes an eye speculum inserted. With the eye in neutral position, the conjunctiva was lifted in the infranasal quadrant with the help of Moorsfields forceps and using Westcott's scissors a small incision was made in the conjunctiva. A 19 gauge Stephens's cannula was carefully placed subconjuctivally into the Sub-Tenon's space.

In group 1, 5 ml of local anaesthetic solution comprising 2.5 ml of 2% lignocaine with 1:200,000 adrenaline, 15 IU/ml of hyaluronidase and 2.5 ml of 0.5% bupivacaine was injected over thirty seconds. After the injection orbital pressure was applied for two minutes.

In group 2, 3 ml of the same anaesthetic solution described above was injected and cannula withdrawn followed by application of orbital pressure for 2 minutes. A further 2 ml of the same anaesthetic solution was injected through the same conjunctival incision with approx three minutes between the two injections.

Intraocular pressures were measured by a hand held tonometer (knowa) prior to injection and six minutes after the first (or sole) injection and compared with pre-injection value.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Benoximate, lignocaine, adrenaline, hyaluronidase, bupivacaine
Primary outcome measureMeasurement of movement was performed by the operating surgeon who was unaware of the anaesthetic technique used in all four quadrants (inferior, superior, redial, lateral) using a vernier calliper and scored according to movement:
0 = no movement
1 = movement of less than 2 mm
2 = movement of more than 2 mm

Motor function was evaluated at two time intervals, 3 and 6 minutes after the initial injection. Overall movement score was obtained by combining the scores of these four muscles. This score ranged from 0 (no movement) to 8 (complete movement) and was categorised into two groups, akinesia (score 0 - 4) and no akinesia (score 5 - 8).

All measured during the surgery.
Secondary outcome measuresChemosis and subconjuctival haemorrhage were also assessed by surgeons before starting surgery as mild, moderate or severe. All measured during the surgery.
Overall study start date01/06/2003
Completion date31/12/2003

Eligibility

Participant type(s)Patient
Age groupOther
SexBoth
Target number of participants60
Total final enrolment60
Key inclusion criteria1. American Society of Anaesthesiologists (ASA) I - III patients undergoing cataract surgery
2. No age range, both male and female patients
Key exclusion criteria1. Allergy to any of the drugs administered
2. Impaired mental status
3. Uncontrolled glaucoma
4. Clotting abnormalities
5. Recent surgical procedure on the same eye
Date of first enrolment01/06/2003
Date of final enrolment31/12/2003

Locations

Countries of recruitment

  • Ireland

Study participating centre

South Infirmary Hospital
Cork
-
Ireland

Sponsor information

Cork University Hospital (Ireland)
University/education

Wilton
Cork
-
Ireland

ROR logo "ROR" https://ror.org/04q107642

Funders

Funder type

Other

Investigator initiated study - no extra funding required as Sub-Tenon's block is routinely used

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 26/03/2009 30/12/2020 Yes No

Editorial Notes

30/12/2020: The following changes have been made:
1. Publication reference added.
2. The final enrolment number has been added from the reference.